Lorenzo Lorusso

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Lorenzo Lorusso, MD, is the Head of the Multiple Sclerosis (SM)/Amyotrophic Lateral Sclerosis (ALS) Centre and a Consultant Neurologist at Mellino Mellini Hospital, Chiari-Brescia, Italy. He serves on the Scientific Committee of Associazione Malati di CFS onlus, a patient advocacy group for chronic fatigue syndrome in Pavia, Italy and on the scientific committee for creating recommendations for the Italian National Agency for Health Regional Service (AGENAS) of the Italian National Institute of Health on CFS/ME.

EUROMENE[edit | edit source]

Dr. Lorusso is a member of the Working Group on dissemination and exploitation, patient involvement, digitalisation on behalf of the EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[1]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. http://www.cost.eu/COST_Actions/ca/CA15111?management
  2. Carlo-Stella, N; Lorusso, L; Candura, SM; Cuccia, M (2004), "Chronic fatigue syndrome: a review", Recenti Prog Med, 96 (11): 546-52, PMID 15598093 
  3. Carlo-Stella, N; Badulli, C; De Silvestri, A; Bazzichi, L; Martinetti, M; Lorusso, L; Bombardieri, S; Salvaneschi, L; Cuccia, M (2006), "A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles", Clinical and Experimental Rheumatology, 24 (2): 179-82, PMID 16762155 
  4. Carlo-Stella, N; Bozzini, S; De Silvestri, A; Sbarsi, I; Pizzochero, C; Lorusso, L; Martinetti, M; Cuccia, M (2009), "Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome", International Journal of Immunopathology and Pharmacology, 22 (3): 745-54, doi:10.1177/039463200902200320, PMID 19822091 
  5. Lorusso, Lorenzo; Mikhaylova, SV; Capelli, Enrica; Ferrari, D; Ngonga, GK; Ricevuti, Giovanni (2009), "Immunological aspects of chronic fatigue syndrome", Autoimmun Rev, 8 (4): 287-91, doi:10.1016/j.autrev.2008.08.003, PMID 18801465 
  6. Capelli, Enrica; Zola, R; Lorusso, Lorenzo; Venturini, Luigi; Sardi, F; Ricevuti, Giovanni (2010), "Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]: An Update", International Journal of Immunopathology and Pharmacology, 23 (4): 981-989, doi:10.1177/039463201002300402, PMID 21244747 
  7. Capelli, Enrica; Lorusso, Lorenzo; Ghitti, M; Venturini, Luigi; Cusa, C; Ricevuti, Giovanni (2015), "Chronic fatigue syndrome: Features of a population of patients from northern Italy", International Journal of Immunopathology and Pharmacology, doi:10.1177/0394632015572074 
  8. Maltese, PE; Venturini, L; Poplavskaya, E; Bertelli, M; Cecchin, S; Granato, M; Nikulina, SY; Salmina, A; Aksyutina, N; Capelli, Enrica; Ricevuti, Giovanni; Lorusso, Lorenzo (2016), "Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome", Genet Mol Res, 15 (3), doi:10.4238/gmr.15038717 
  9. Panelli, Simona; Lorusso, Lorenzo; Balestrieri, Alessandro; Lupo, Giuseppe; Capelli, Enrica (2017), "XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable", Frontiers in Public Health, 5 (108), doi:10.3389/fpubh.2017.00108 
  10. Bozzini, S; Albergati, A; Capelli, Enrica; Lorusso, Lorenzo; Gazzaruso, C; Pelissero, G; Falcone, C (2018), "Cardiovascular characteristics of chronic fatigue syndrome.", Biomedical Reports, 8 (1): 26–30, doi:10.3892/br.2017.1024, PMID 29399336 
  11. Estévez-López, Fernando; Castro-Marrero, Jesus; Wang, Xia; Bakken, Inger Johanne; Ivanovs, Andrejs; Nacul, Luis; Sepúlveda, Nuno; Strand, Elin B.; Pheby, Derek; Alegre, José; Scheibenbogen, Carmen; Shikova, Evelina; Lorusso, Lorenzo; Capelli, Enrica; Sekulic, Slobodan; Lacerda, Eliana; Murovska, Modra (Sep 1, 2018). "Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review". BMJ Open. 8 (9): e020817. doi:10.1136/bmjopen-2017-020817. ISSN 2044-6055. PMID 30181183. 

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.